Documents
Application Sponsors
NDA 020784 | SANOFI AVENTIS US | |
Marketing Status
Application Products
001 | SPRAY, METERED;NASAL | 0.055MG/SPRAY | 0 | NASACORT HFA | TRIAMCINOLONE ACETONIDE |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 2004-04-07 | STANDARD |
CDER Filings
SANOFI AVENTIS US
cder:Array
(
[0] => Array
(
[ApplNo] => 20784
[companyName] => SANOFI AVENTIS US
[docInserts] => ["",""]
[products] => [{"drugName":"NASACORT HFA","activeIngredients":"TRIAMCINOLONE ACETONIDE","strength":"0.055MG\/SPRAY","dosageForm":"SPRAY, METERED;NASAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"NASACORT HFA","submission":"TRIAMCINOLONE ACETONIDE","actionType":"0.055MG\/SPRAY","submissionClassification":"SPRAY, METERED;NASAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)